Over-Impacted, Under-Represented: Addressing Health Disparities in Multiple Sclerosis

Released On
July 19, 2022

Expires On
July 19, 2023

Media Type
Internet

Completion Time
60 minutes

Specialty
Neurology, Primary Care

Topic(s)
Multiple Sclerosis

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Purdue University College of Pharmacy Office of Continuing Education and Professional Development and Efficient LLC and was developed in partnership with the Accelerated Cure Project and Multiple Sclerosis Foundation.

 

Supported by educational grants from EMD Serono and Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

The target audience for this initiative includes MS specialists, general neurologists, nurse practitioners, physician assistants, and other healthcare professionals involved in the diagnosis and long-term management of patients with MS.

Program Overview

The prevalence of MS in racial and ethnic minority groups appears to be growing and its prognosis among these groups is often worse. With its historical management strategies formulated almost exclusively around patients of Caucasian descent, MS has a pressing need for improved approaches in patients of minority backgrounds. However, minimal guidance is publicly available on how to best meet the needs of diverse patient populations. Some of the greatest barriers to patient care among minority groups are their perceptions and experiences with healthcare providers. The organizers hope to address this gap by documenting the perspectives of racial and ethnic minority patients related to their MS care. These perspectives will then be embedded into expert discussion alongside supporting evidence of and resources to help providers address the issues raised. This unique CME initiative will enable learners to develop more culturally conscious clinical and communication-based skills to better assess and address the needs of minority patients with MS.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Identify key variations in clinical presentation between different racial/ethnic populations with MS, and use these to apply individualized treatment strategies to achieve improved outcomes for these patients.
  • Discuss sociocultural views that may discourage racial and ethnic minority groups from seeking and/or complying with medical care, and apply strategies to form a comfortable and supportive management approach for patients of different backgrounds.
  • Review both interpersonal and publicly available approaches to the support of clinical trial engagement among racial and ethnic minority patients with MS in order to better inform and encourage patient participation.

 

Faculty

FACULTY_NAME

Mitzi Williams, MD, FAAN (Chair/Moderator)

Neurologist and Multiple Sclerosis Specialist
Founder and Medical Director, Joi Life Wellness Group
Atlanta, GA

FACULTY_NAME

Annette Okai, MD

Director, Neuroimmunology and Multiple Sclerosis Research
North Texas Institute of Neurology and Headache
Clinical Associate Professor of Neurology
Texas Tech University Health Science Center
Plano, TX

FACULTY_NAME

Stephen Krieger, MD, FAAN

Associate Professor of Neurology
Icahn School of Medicine at Mount Sinai
Attending Physician
Corinne Goldsmith Dickinson Center for MS
New York, NY


Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Purdue University College of Pharmacy Office of Continuing Education and Professional Development and Efficient LLC and was developed in partnership with the Accelerated Cure Project and Multiple Sclerosis Foundation. Purdue University is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Purdue designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

To ensure compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Purdue University requires that all individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflicts of interest identified are thoroughly assessed by Purdue University to ensure fair balance, scientific rigor, and accepted patient care recommendations of the educational activity.

Planners’ and Managers’ Disclosure

All additional planning committee members, staff and reviewers of Efficient LLC and Purdue University College of Pharmacy have no relationships to disclose.

Mitzi Williams, MD, FAAN
  • Grants/Research Support: EMD Serono, Genentech, Novartis
  • Consultant: Abbvie, Alexion, Biogen Idec, Bristol Myers Squibb, EMD Serono, Genentech, Jansen, Novartis, Sanofi Genzyme, TG Therapeutics
  • Speakers Bureau: Abbvie, Biogen Idec, Bristol Myers Squibb, EMD Serono, Genentech, Jansen, Novartis, Sanofi Genzyme
  • Advisory Board Membership: Abbvie, Alexion, Biogen Idec, Bristol Myers Squibb, EMD Serono, Genentech, Jansen, Novartis, Sanofi Genzyme, TG Therapeutics
Annette Okai, MD
  • Grants/Research Support: Biogen, EMD Serono, Genentech, Novartis, Sanofi Genzyme
  • Principal Investigator for a Drug Study: Alexion, Biogen, Bristol Myers Squibb, EMD Serono, Genentech, Novartis, Sanofi Genzyme
  • Consultant: Biogran, Bristol Myers Squibb, EMD Serono, Genentech, Novartis, Sanofi Genzyme
Stephen Krieger, MD, FAAN
  • Grants/Research Support: Biogen, BMS, Novartis
  • Principal Investigator for a Drug Study: Sanofi
  • Consultant: Biogen, EMD Serono, Genentech, Genzyme/Sanofi, Novartis, Octave, TG Therapeutics
  • Honorarium Recipient (Non-CE Related): Non-promotional speaking with Biogen, EMD Serono, Genentech

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the pre- and post-assessment and submit the evaluation form.

Certificates will be emailed to the participant.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Contact Information

For CME questions please contact: pharmacy-cecr@purdue.edu